MONROVIA, Md. (AP) — MONROVIA, Md. (AP) — GlycoMimetics Inc. (GLYC) on Wednesday reported a loss of $2.3 million in its first quarter. The Monrovia, Maryland-based company said it had a loss of 4 ...

Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top ...

In light of current market conditions, we explore three... GlycoMimetics ( (GLYC) ) has shared an update. GlycoMimetics and Crescent Biopharma have updated their investor presentation related to ...

GLYC)'s merger with Crescent Biopharma, Inc. Upon closing of the proposed transaction, GlycoMimetics stockholders are expected to own approximately 3.1% of the combined company. If you are a ...

1 Day GLYC 5.39% DJIA 1.07% Russell 2K 1.53% Health Care/Life Sciences -0.64% ...

Short interest in GlycoMimetics Inc (NASDAQ:GLYC) decreased during the last reporting period, falling from 2.58M to 2.46M. This put 4.62% of the company's publicly available shares short.

ROCKVILLE, MD – GlycoMimetics Inc. (NASDAQ:GLYC), a pharmaceutical company with a market capitalization of $17.28 million, has announced the impending departure of two top executives ...

We are headquartered at the Empire State Building in New York City and are investigating: GlycoMimetics, Inc. (NASDAQ: GLYC), relating to a proposed merger with First Crescent Biopharma ...

GlycoMimetics, Inc. (NASDAQ: GLYC), relating to a proposed merger with First Crescent Biopharma, Inc. Under the terms of the agreement, pre-acquisition GlycoMimetics stockholders are expected to ...